Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Krebs Biochemicals & Industries Ltd.

  • NSE: KREBSBIO

  • BSE: 524518

  • Q
  • V
  • T
0.00/100

Quality Score

Not Eligible
3.00/100

Valuation Score

Expensive Valuation
57.25/100

Technical Score

Technically Neutral
Broker Average Rating

0.00

Broker Average Rating

MFI

58.25

MFI is mid-range

50Day SMA Rs

85.60 Rs

price crossed below SMA50 today

Quality score

0.00

Not Eligible

30Day SMA Rs

86.49 Rs

price crossed below SMA30 today

Broker Covering stock

0.00

None Broker Covering stock

Broker 6M Target upgrade

0.00

None Broker 6M Target upgrade

Broker 6M Target downgrade

0.00

None Broker 6M Target downgrade

Momentum score

57.25

Technically Neutral

Price to Book Ratio

-11.03

Negative Price to Book

Broker Reports in 1Yr

0.00

None Broker Reports in 1Yr

TTM PE Ratio

-6.09

Negative PE Trailing 12M

Broker 6M Reco upgrade

0.00

None Broker 6M Reco upgrade

RSI

51.01

RSI is mid-range

Net Profit Qtr Cr

-6.72 Cr

Negative Net Profit Qtr Cr

AVG Broker Target

0.00 %

No targets last year

Operating Revenues Qtr Cr

11.57 Cr

Below industry Median

MACD

0.29

MACD above Center

Valuation score

3.00

Expensive Valuation

MACD Signal Line

0.52

MACD above Center

FII holding holding %

0.01 %

No change in FII holding

Promoter holding holding %

70.05 %

Promoter holding increased by 2.7%.

MF holding holding %

0.00 %

MF holding holding

Broker 6M Reco downgrade

0.00

None Broker 6M Reco downgrade

100Day SMA Rs

81.51 Rs

Price above SMA 81.51

Institutions holding holding %

0.01 %

No change in Institutions holding

AVG Broker Target

0.00 Rs

No targets last year

200Day SMA Rs

82.51 Rs

Price above SMA 82.51

NSE KREBSBIO
87.00
  • 85.05 Close
  • 87.25 Open
  • 1.29 K Volume
Today Low/High
Low 84.95
High 88.00
52 Week Low/High
24-03-2020 60.65
04-08-2020 111.35

Peer Comparison

All values except ratios in INR(Crores)

Stock Name Current Price Rs PE TTM Price To Earnings Market Capitalization In Cr Dividend Yield 1yr % Net Profit Qtr Cr Net Profit Annual Growth YoY % Operating Revenues Qtr Cr Revenue Growth Qtr YoY Price To Book Value
Krebs Biochemicals & Industries Ltd. 86.95 -6.1 170.6 0 -6.73 0 11.56 148.23 -11.04
Sun Pharmaceutical Industries Ltd. 489.65 459.63 117481.72 0.81 -2429.81 0 7585.25 -9.43 2.39
Dr. Reddy's Laboratories Ltd. 5112.2 44.79 84964.76 0.48 586.9 0 4426.5 14.72 5.45
Divi's Laboratories Ltd. 3060.75 50.9 81247.6 0.52 492.06 0 1730.47 48.8 11.11
Cipla Ltd. 770.1 37.68 62089.31 0.51 571.42 0 4346.16 8.95 3.86
Torrent Pharmaceuticals Ltd. 2719.25 40.72 46020.58 1.17 321 0 2056 1.68 9.54
Lupin Ltd. 998.9 -96.86 45260.15 0.6 108.14 0 3527.86 -20.16 3.59
Aurobindo Pharma Ltd. 772.1 15.04 45237.33 0.55 792.68 0 5924.78 8.81 2.69